Business Description
![SCYNEXIS Inc SCYNEXIS Inc logo](https://static.gurufocus.com/logos/0C0000AL3T.png?14)
SCYNEXIS Inc
NAICS : 325412
SIC : 2834
ISIN : US8112922005
Description
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.7 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -0.46 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.17 | |||||
Beneish M-Score | -2.08 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 19.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.76 | |||||
9-Day RSI | 29.7 | |||||
14-Day RSI | 35.07 | |||||
6-1 Month Momentum % | 28.57 | |||||
12-1 Month Momentum % | -26.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.75 | |||||
Quick Ratio | 3.75 | |||||
Cash Ratio | 2.89 | |||||
Days Inventory | 197.96 | |||||
Days Sales Outstanding | 83.7 | |||||
Days Payable | 137.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.7 | |||||
Shareholder Yield % | 44.3 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -55.82 | |||||
Operating Margin % | -536.96 | |||||
Net Margin % | -366.09 | |||||
FCF Margin % | -105.34 | |||||
ROE % | -45.08 | |||||
ROA % | -26.9 | |||||
ROIC % | -126.51 | |||||
ROC (Joel Greenblatt) % | -1188.78 | |||||
ROCE % | -30.47 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.36 | |||||
PB Ratio | 1.05 | |||||
Price-to-Tangible-Book | 1.02 | |||||
EV-to-EBIT | -0.16 | |||||
EV-to-EBITDA | -0.16 | |||||
EV-to-Revenue | 0.55 | |||||
EV-to-Forward-Revenue | 0.2 | |||||
EV-to-FCF | -0.6 | |||||
Price-to-Net-Current-Asset-Value | 1.31 | |||||
Price-to-Net-Cash | 2.39 | |||||
Earnings Yield (Greenblatt) % | -634.2 | |||||
FCF Yield % | -16.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SCYNEXIS Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 9.667 | ||
EPS (TTM) ($) | -0.74 | ||
Beta | 0.17 | ||
Volatility % | 78.8 | ||
14-Day RSI | 35.07 | ||
14-Day ATR ($) | 0.074728 | ||
20-Day SMA ($) | 1.857053 | ||
12-1 Month Momentum % | -26.62 | ||
52-Week Range ($) | 1.395 - 3.855 | ||
Shares Outstanding (Mil) | 37.86 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SCYNEXIS Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SCYNEXIS Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
SCYNEXIS Inc Frequently Asked Questions
What is SCYNEXIS Inc(LTS:0L49)'s stock price today?
The current price of LTS:0L49 is $1.67. The 52 week high of LTS:0L49 is $3.86 and 52 week low is $1.40.
When is next earnings date of SCYNEXIS Inc(LTS:0L49)?
The next earnings date of SCYNEXIS Inc(LTS:0L49) is 2024-11-13 Est..
Does SCYNEXIS Inc(LTS:0L49) pay dividends? If so, how much?
SCYNEXIS Inc(LTS:0L49) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |